Introduction
Varicose veins are common, with an estimated prevalence of about 8% in men and 16% in women.' Their treatment imposes substantial costs on the NHS, whether measured by operations and bed days2 or financially.3 ' At a time when health care systems in the United Kingdom and abroad are trying to contain the rising costs of health care, clinicians are increasingly required to show that the care they deliver is effective and efficient. In the United States, for example, the state of Oregon has attempted to introduce a system of health care rationing that gives priority to those medical conditions for which treatment has proven benefit. 5 In the United Kingdom the government has introduced managed competition into the NHS. 6 In this internal market health authorities and fundholding practices are expected to purchase cost effective care from competing provider units.
To achieve this purchasers will need valid and reliable measures of patient outcome. There are few such measures for varicose veins, which may help to explain why there is no consensus about the relative merit of the two main forms of treatment -namely, injection sclerotherapy and surgery.7 " Consequently, treatment for this condition has been given a low priority by some health authorities; North East Thames Regional Health Authority, for example, has advised its districts to (F4). In contrast, questions 3 ("At what time of the day were your varicose veins usually most painful or aching?") and 7 ("Do you take 'water tablets' for ankle swelling?") are isolated in factors F5 and F6 respectively. These two factors are unimportant (in the sense that their eigenvalues are less than 1 1) and each contains only one question; hence there is little evidence that they represent any clinically distinct health factor. Thus questions 3 and 7 failed two of the three criteria and were removed from the definitive questionnaire. This achieved a Cronbach's alpha statistic of 0-72, thus satisfying the criterion proposed by Helmstadter.23 Figure 1 shows the distribution of the resulting varicose vein severity scores. For both referred and non-referred patients the scores are skewed but quite close to normality. For referred patients they ranged from 3-0 to 62-8 (median 19 1); for non-referred they ranged from 3-4 to 71P0 (median 19-3). That there is no significant difference between these two distributions may reflect variations in referral behaviour between general practitioners.
VALIDATING THE QUESTIONNAIRE Table 1 shows that the varicose vein severity scores achieve highly significant negative correlations with all eight scales of the SF-36 health profile. Four of these correlations exceed 04 in absolute magnitude: those with physical functioning, pain, social functioning, and role limitations attributed to emotional problems; only the correlation with general . X e . 6 X w e s . 6 X e D < w @ w ---:
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